Covered recipient · General Payments record
MARGARET KEITH
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Hospice and Palliative Medicine
General Payments · PY2018–2024
$1,410.46
- Reported across 77 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $277.01 | 14 |
| Education | $13.35 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $73.04 | 4 |
| Astellas Pharma US Inc | $60.43 | 3 |
| Sage Therapeutics, Inc. | $42.00 | 2 |
| Organon LLC | $27.35 | 1 |
| SHIELD THERAPEUTICS INC | $23.99 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.33 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $17.02 | 1 |
| OptumHealth Care Solutions, LLC | $13.85 | 1 |
| MILLICENT US INC | $13.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $21.06 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139295964 | CMS |
| Astellas Pharma US Inc | $20.13 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139285462 | CMS |
| Astellas Pharma US Inc | $19.24 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139382574 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.33 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086123942 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $17.02 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154709639 | CMS |
| MILLICENT US INC | $13.35 | 04/17/2024 | Education | Undisputed | 01/23/2026 | 1150908481 | CMS |
| OptumHealth Care Solutions, LLC | $13.85 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154274168 | CMS |
| Organon Llc | $27.35 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136237338 | CMS |
| PFIZER INC. | $17.65 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131293285 | CMS |
| PFIZER INC. | $14.23 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131771174 | CMS |
| PFIZER INC. | $18.85 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131909544 | CMS |
| PFIZER INC. | $22.31 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131453564 | CMS |
| Sage Therapeutics, Inc. | $20.45 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120396031 | CMS |
| Sage Therapeutics, Inc. | $21.55 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120398467 | CMS |
| SHIELD THERAPEUTICS INC | $23.99 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150132841 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.